[CAS NO. 2040291-27-6] LLY-283
Please click "REQUEST A QUOTE" button if you need other sizes or
custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis,
please:
PRODUCTS SPECIFICATIONS [2040291-27-6]
Catalog
SLK-S8883
Brand
Selleck
CAS
2040291-27-6
DESCRIPTION [2040291-27-6]
Overview
| MDL | - |
|---|---|
| Molecular Weight | 342.35 |
| Molecular Formula | C17H18N4O4 |
| SMILES | NC1=C2C(N([C@H]3[C@@H]([C@@H]([C@@H]([C@@H](C4=CC=CC=C4)O)O3)O)O)C=C2)=NC=N1 |
For research use only.
Storage
3 years,-20°C,powder
1 years,-80°C,in solvent
1 years,-80°C,in solvent
Shipping
Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Preparing Stock Solutions
| 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.9210 mL | 14.6049 mL | 29.2099 mL |
| 5 mM | 0.5842 mL | 2.9210 mL | 5.8420 mL |
| 10 mM | 0.2921 mL | 1.4605 mL | 2.9210 mL |
| 50 mM | 0.0584 mL | 0.2921 mL | 0.5842 mL |
Description
LLY-283 is a novel and selective inhibitor of . LLY-283 inhibits PRMT5 enzymatic activity in vitro and in cells with IC50 of 22 nM and 25 nM, respectively. LLY-283 shows antitumor activity.
In vitro
LLY-283 inhibits PRMT5 enzymatic activity in vitro and in cells with IC50 of 22 ± 3 and 25 ± 1 nM, respectively. LLY-283 directly binds to and occupies the SAM pocket. LLY-283 is a low nanomolar enzymatic inhibitor of the PRMT5:MEP50 complex in biochemical assays and is selective for PRMT5 over other methyltransferases including related family members.
In vivo
LLY-283 shows antitumor activity in mouse xenografts when dosed orally and can serves as an excellent probe molecule for understanding the biological function of PRMT5 in normal and cancer cells. LLY-283 can be used as an in vivo tool compound to evaluate the pharmacology of PRMT5 inhibition.
Powered by Arctom Copyright © 2025 Arctom.
All rights reserved.